Structure-based optimizations of a necroptosis inhibitor (SZM594) as novel protective agents of acute lung injury
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Structure-based optimizations of a necroptosis inhibitor (SZM594) as novel protective agents of acute lung injury
Authors
Keywords
Acute lung injury, RIPK1, RIPK3, Necroptosis, Design
Journal
CHINESE CHEMICAL LETTERS
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2021-09-24
DOI
10.1016/j.cclet.2021.09.059
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Protective Effects of Kirenol against Lipopolysaccharide-Induced Acute Lung Injury through the Modulation of the Proinflammatory NFκB Pathway and the AMPK2-/Nrf2-Mediated HO-1/AOE Pathway
- (2021) Frank Cheau-Feng Lin et al. Antioxidants
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
- (2020) Chaolin Huang et al. LANCET
- Targeting necroptosis in anticancer therapy: mechanisms and modulators
- (2020) Ying Wu et al. Acta Pharmaceutica Sinica B
- Receptor-interacting protein kinase 1 (RIPK1) as a therapeutic target
- (2020) Lauren Mifflin et al. NATURE REVIEWS DRUG DISCOVERY
- The role of necroptosis in cancer: A double-edged sword?
- (2019) Xia Qin et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Identification of the Raf kinase inhibitor TAK‐632 and its analogues as potent inhibitors of necroptosis by targeting RIPK1 and RIPK3
- (2019) Xiaofei Chen et al. BRITISH JOURNAL OF PHARMACOLOGY
- N-(7-Cyano-6-(4-fluoro-3-(2-(3-(trifluoromethyl)phenyl)acetamido)phenoxy)benzo[d]thiazol-2-yl)cyclopropanecarboxamide (TAK-632) Analogues as Novel Necroptosis Inhibitors by Targeting Receptor-Interacting Protein Kinase 3 (RIPK3): Synthesis, Structure–Activity Relationships, and in Vivo Efficacy
- (2019) Hao Zhang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Targeting RIPK1 for the treatment of human diseases
- (2019) Alexei Degterev et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Small-Molecule Inhibitors of Necroptosis: Current Status and Perspectives
- (2019) Chunlin Zhuang et al. JOURNAL OF MEDICINAL CHEMISTRY
- The potential role of necroptosis in inflammaging and aging
- (2019) Gordon H. Royce et al. GeroScience
- Innate immune priming in the absence of TAK1 drives RIPK1 kinase activity–independent pyroptosis, apoptosis, necroptosis, and inflammatory disease
- (2019) R.K. Subbarao Malireddi et al. JOURNAL OF EXPERIMENTAL MEDICINE
- A dominant autoinflammatory disease caused by non-cleavable variants of RIPK1
- (2019) Panfeng Tao et al. NATURE
- Necroptosis in development and diseases
- (2018) Bing Shan et al. GENES & DEVELOPMENT
- Necroptosis: a regulated inflammatory mode of cell death
- (2018) Yogesh K. Dhuriya et al. Journal of Neuroinflammation
- Cell Death in the Lung: The Apoptosis–Necroptosis Axis
- (2018) Maor Sauler et al. Annual Review of Physiology
- Discovery of a First-in-Class Receptor Interacting Protein 1 (RIP1) Kinase Specific Clinical Candidate (GSK2982772) for the Treatment of Inflammatory Diseases
- (2017) Philip A. Harris et al. JOURNAL OF MEDICINAL CHEMISTRY
- Receptor-interacting protein kinase 3 promotes platelet activation and thrombosis
- (2017) Yiwen Zhang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Necrostatin-1 enhances the resolution of inflammation by specifically inducing neutrophil apoptosis
- (2016) Hongyu Jie et al. Oncotarget
- Necroptosis and its role in inflammation
- (2015) Manolis Pasparakis et al. NATURE
- Pore-Forming Toxins Induce Macrophage Necroptosis during Acute Bacterial Pneumonia
- (2015) Norberto González-Juarbe et al. PLoS Pathogens
- Targeting hypoxia signalling for the treatment of ischaemic and inflammatory diseases
- (2014) Holger K. Eltzschig et al. NATURE REVIEWS DRUG DISCOVERY
- TRAIL induces necroptosis involving RIPK1/RIPK3-dependent PARP-1 activation
- (2012) S Jouan-Lanhouet et al. CELL DEATH AND DIFFERENTIATION
- The Dual Functions of Receptor Interacting Protein 1 in Fas-Induced Hepatocyte Death During Sepsis
- (2011) Sam I. McNeal et al. SHOCK
- Phosphorylation-Driven Assembly of the RIP1-RIP3 Complex Regulates Programmed Necrosis and Virus-Induced Inflammation
- (2009) YoungSik Cho et al. CELL
- Identification of RIP1 kinase as a specific cellular target of necrostatins
- (2008) Alexei Degterev et al. Nature Chemical Biology
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started